Amends Medicare Advantage plans to ensure mental health and substance use benefits parity. Mandates standards-based necessity determination and NQTL analyses. Imposes penalties for non-compliance. Extends parity to drug plans. Directs regulation issuance within 18 months. Allocates $10 million for implementation.
Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the risk subdomain are described.
All other risk subdomains had no coverage in this document.
Risk Coverage Summary
This document has minimal coverage of AI risk domains. It primarily addresses healthcare policy and insurance regulation with only one explicit mention of AI-related technology in the context of medical necessity determinations (subdomain 7.4). The document does not substantively address AI risks, harms, or safety concerns.
Good coverage — Comprehensive governance measures or mitigations with clear procedures relating to the sector are explicitly described.
Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the sector are described.
All other sectors had no coverage in this document.
Sectors Summary
This document primarily governs the Health Care and Social Assistance sector, specifically Medicare Advantage organizations and prescription drug plan sponsors. It also has implications for the Finance and Insurance sector as these organizations provide health insurance products.
Hard Law
Legislative Status Summary
This is a binding federal statute enacted by the United States Congress that amends the Social Security Act. It contains mandatory obligations with enforcement mechanisms including civil monetary penalties for non-compliance.
Proposer
Target
Enforcer
Monitor
Lifecycle stages covered by the documents, as defined in the OECD Framework for the Classification of AI Systems
AI Lifecycle Summary
The document does not comprehensively address AI lifecycle stages. It mentions AI and related technologies only in the context of medical necessity determinations and NQTL analyses, requiring disclosure of their use but not governing their development, deployment, or monitoring as AI systems.
Terms relating to technical scope that are mentioned or implicitly referenced in the document
No technical scope terms identified.
Technical Scope Summary
The document mentions AI technology, machine learning, and clinical decision-making technology only as examples of tools that may be used in medical necessity determinations. It does not define these terms, distinguish between AI models and systems, or specify any technical characteristics, compute thresholds, or model types.
Document data from AGORA, CSET Emerging Technology Observatory.